Your browser doesn't support javascript.
loading
Signalling of Adrenoceptors: Canonical Pathways and New Paradigms.
Mastos, Chantel; Xu, Xiaomeng; Keen, Alastair C; Halls, Michelle L.
Afiliação
  • Mastos C; Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.
  • Xu X; Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.
  • Keen AC; Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.
  • Halls ML; Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia. michelle.halls@monash.edu.
Handb Exp Pharmacol ; 2024 Jan 17.
Article em En | MEDLINE | ID: mdl-38227198
ABSTRACT
The concept of G protein-coupled receptors initially arose from studies of the ß-adrenoceptor, adenylyl cyclase, and cAMP signalling pathway. Since then both canonical G protein-coupled receptor signalling pathways and emerging paradigms in receptor signalling have been defined by experiments focused on adrenoceptors. Here, we discuss the evidence for G protein coupling specificity of the nine adrenoceptor subtypes. We summarise the ability of each of the adrenoceptors to activate proximal signalling mediators including cAMP, calcium, mitogen-activated protein kinases, and protein kinase C pathways. Finally, we highlight the importance of precise spatial and temporal control of adrenoceptor signalling that is controlled by the localisation of receptors at intracellular membranes and in larger protein complexes.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Handb Exp Pharmacol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Handb Exp Pharmacol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália